Insider filing · TARS
Elizabeth Yeu Lin
Chief Medical Officer
profile →
Tarsus Pharmaceuticals, Inc.
TARS · Healthcare · 35 filings in 24 months
ticker →
Elizabeth Yeu Lin sold $1.2M of Tarsus Pharmaceuticals (TARS)
Executed Sep 4, disclosed Sep 9, 5 days later.
Value, as filed
$1.2M
13,953 sh across 4 lots
Executed
Sep 4
the trade date, as filed
Disclosed
Sep 9
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ELElizabeth Yeu Lin (Chief Medical Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $1.2M of TARS (13,953 sh across 4 lots, as filed), executed Sep 4.
The name
TARSHealthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Elizabeth Yeu Lin in TARS
TARSSALE
Tarsus Pharmaceuticals, Inc.
$898K11,578 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 4:29 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. $165K
2,078 sh × $79.50
Exec Dec 16 2025
Filed Dec 17 2025 · 5:30 PM ET